DIFFERENTIATING AGENTS IN THE TREATMENT OF HUMAN MALIGNANCIES

被引：32

作者：

CHESON, BD ^{[1
]}

JASPERSE, DM ^{[1
]}

CHUN, HG ^{[1
]}

FRIEDMAN, MA ^{[1
]}

机构：

[1] EMMES CORP, POTOMAC, MD 20854 USA

来源：

CANCER TREATMENT REVIEWS | 1986年 / 13卷 / 03期

关键词：

D O I：

10.1016/0305-7372(86)90001-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：129 / 145

页数：17

共 191 条

[1]

AKIYAMA S, 1981, GANN, V72, P742

[2] LOW-DOSE ARABINOSYL CYTOSINE IN ACUTE-LEUKEMIA AFTER A MYELODYSPLASTIC SYNDROME AND IN ELDERLY LEUKEMIA [J].

ALESSANDRINO, EP ;

ORLANDI, E ;

BRUSAMOLINO, E ;

LAZZARINO, M ;

BERNASCONI, C .

AMERICAN JOURNAL OF HEMATOLOGY, 1985, 20 (02) :191-193

[3]

ALFTHAN O, 1983, EUR UROL, V9, P6

[4]

ALTMAN AJ, 1982, PEDIATR RES, V16, pA714

[5]

AMADORI S, 1984, P AACR, V25, pA732

[6]

ANKERST J, 1984, CANCER IMMUNOL IMMUN, V17, P69

[7] 13-CIS-RETINOIC ACID DOES NOT INCREASE THE TRUE REMISSION RATE AND THE DURATION OF TRUE REMISSION (INDUCED BY CYTO-TOXIC CHEMOTHERAPY) IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA [J].

ARLIN, ZA ;

MERTELSMANN, R ;

BERMAN, E ;

GEE, T ;

KURLAND, E ;

CHAGANTI, RSK ;

JHANWAR, SC ;

MOORE, MAS ;

CLARKSON, BD .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (04) :473-476

[8] DIFFERENTIATION OF MYELOID LEUKEMIC-CELLS - NEW POSSIBILITIES FOR THERAPY [J].

BACCARANI, M ;

TURA, S .

BRITISH JOURNAL OF HAEMATOLOGY, 1979, 42 (03) :485-487

[9] LOW-DOSE ARABINOSYL CYTOSINE FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES AND SUBACUTE MYELOID-LEUKEMIA [J].

BACCARANI, M ;

ZACCARIA, A ;

BANDINI, G ;

CAVAZZINI, G ;

FANIN, R ;

TURA, S .

LEUKEMIA RESEARCH, 1983, 7 (04) :539-545

[10]

BALL ED, 1984, J CLIN INVEST, V73, P1072, DOI 10.1172/JCI111292

← 1 2 3 4 5 6 7 8 9 10 →